pain and shoulder

202

Upload: others

Post on 25-Apr-2022

3 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: PAIN AND SHOULDER
Page 2: PAIN AND SHOULDER

PAIN AND SHOULDER

OCTOBER 27, 2020 | 5:00–6:00 P.M. ET

Page 3: PAIN AND SHOULDER

KOJI AOKI

Page 4: PAIN AND SHOULDER

Effects of Shoulder Distraction on Canine Shoulder

Arthroscopy

Koji Aoki, Jun-Yan Sek, Fernando Freitas, Miriam Bates

Presenter: Koji Aoki, BVSc, MVS, DACVS-SA

University of Saskatchewan

Page 5: PAIN AND SHOULDER

Disclosure

• No conflict of interest to this study

Page 6: PAIN AND SHOULDER

Background

• Iatrogenic articular cartilage injury (IACI) associated with arthroscopy is common

• IACI in human literatures• 31% IACI in ankle arthroscopy

• J. Vega, 2016

• 77.6 % IACI in knee arthroscopy• J. Compton, 2020

Page 7: PAIN AND SHOULDER

Background

• Use of joint distractor in Vet Med• Decrease IACI and increase procedural success rate

• Canine stifle and hip

• K. Kim, 2016, J, Kim 2019

P. BOTTCHER, 2009

Leipzig Distractor

Page 8: PAIN AND SHOULDER

Background

• Use of joint distractor in Vet Med• Decrease IACI and increase procedural success rate

• Canine stifle and hip

• K. Kim, 2016, J, Kim 2019

• No study • Effect of shoulder joint distraction on arthroscopy

P. BOTTCHER, 2009

Leipzig Distractor

Page 9: PAIN AND SHOULDER

Objective

• To evaluate the effect of shoulder distraction using a Leipzig distractor on

• IACI

• Surgery time

• Visibility and palpability of intra-articular structure

Page 10: PAIN AND SHOULDER

Hypothesis

• Shoulder (Leipzig) distraction device would

• Decrease IACI

• Decrease surgery time

• Improve visibility and palpability of the intra-articular structures

Page 11: PAIN AND SHOULDER

Outline

1. Ex vivo – cadaveric study

2. Clinical case series

Page 12: PAIN AND SHOULDER

1. Cadaveric Study

Page 13: PAIN AND SHOULDER

Material and Methods

• 30 shoulder joints • From 15 large breed canine cadavers

• Body weight 20.7 kg to 42.7 kg (mean 31.3 kg)

• Euthanized unrelated to this study

• Body in -20 °C and thawed to room temperature (22 °C)

Page 14: PAIN AND SHOULDER

Material and Methods

• Non-distraction group (n = 15)• Standard lateral shoulder arthroscopy

• Camera port establishment• Distal to the acromion process• 18g needle• 10 ml of saline infusion • A 2.7mm arthroscope

• An egress port • 18g needle

Page 15: PAIN AND SHOULDER

Material and Methods

• Non-distraction group (n = 15)• Standard lateral shoulder arthroscopy

• Camera port establishment• Distal to the acromion process• 18g needle• 10 ml of saline infusion • A 2.7mm arthroscope

• An egress port • 18g needle

Page 16: PAIN AND SHOULDER

Material and Methods

• Non-distraction group (n = 15)• Standard lateral shoulder arthroscopy

• Instrument port • 18g spinal needle

• 2.7 mm blunt obturator

• 3.4-mm hook tipped probe

Page 17: PAIN AND SHOULDER

Material and Methods

• Distraction group (n = 15)

• Leipzig distractor placement • Prior to establishing ports

• 2.4 mm positive threaded half pin

Page 18: PAIN AND SHOULDER

B

Page 19: PAIN AND SHOULDER

Material and Methods

• Distraction group (n = 15)

• Leipzig distractor placement • Prior to establishing ports

• Camera and egress ports• Same as non-distraction group

• No distraction performed

Page 20: PAIN AND SHOULDER

Material and Methods

• Distraction group (n = 15)

• Joint distraction • Visualizing medial collateral ligament

• To prevent excessive distraction

Medial glenohumeral ligament

Page 21: PAIN AND SHOULDER

Material and Methods

• Distraction group (n = 15)

• Joint distraction

• Instrument port • Same as non-distraction group

• 18g spinal needle

• 2.7 mm blunt obturator

• 3.4-mm hook tipped probe

Page 22: PAIN AND SHOULDER

Material and Methods

• Joint space• Measured on captured digital arthroscopic images

• Using a 3.4-mm hook tipped probe at the middle of medial glenohumeral ligament

Page 23: PAIN AND SHOULDER

Material and Methods

• Visibility and palpability of intra-articular structures • Using a 3.4-mm hook tipped probe

Page 24: PAIN AND SHOULDER

Medial glenohumeral ligament

Page 25: PAIN AND SHOULDER

Medial glenohumeral ligament Subscapularis

Page 26: PAIN AND SHOULDER

Medial glenohumeral ligament Subscapularis Glenoid

Page 27: PAIN AND SHOULDER

Medial glenohumeral ligament Subscapularis Glenoid Supraglenoid Tubercle

Page 28: PAIN AND SHOULDER

Medial glenohumeral ligament Subscapularis Glenoid Supraglenoid Tubercle

Biceps

Page 29: PAIN AND SHOULDER

Medial glenohumeral ligament Subscapularis Glenoid Supraglenoid Tubercle

Biceps Caudal Humeral head

Page 30: PAIN AND SHOULDER

Medial glenohumeral ligament Subscapularis Glenoid Supraglenoid Tubercle

Biceps Caudal Humeral head Caudal synovial pouch

Page 31: PAIN AND SHOULDER

Visibility Score

Score 1 The structure is not visible

Score 2 The structure is partially visible

Score 3 The entire structure is visible

Page 32: PAIN AND SHOULDER

Visibility Score

Score 1 The structure is not visible

Score 2 The structure is partially visible

Score 3 The entire structure is visible

Palpability Score

Score 1 The structure is not palpable

Score 2 The structure is partially palpable OR the entire structure is palpable only with limited angle

Score 3 The entire structure is palpable without restriction in motion

Page 33: PAIN AND SHOULDER

Material and Methods

• Procedural duration • From the beginning of the instrument port establishment

Needle time Probe Time Palpation Time

Total Surgery Time

Visualizing and palpating Intra-articular structures

Page 34: PAIN AND SHOULDER

Material and Methods

• Assessment of IACI • Dissection and disarticulation

• Humeral head and glenoid stained with Indian black

• Measurement of IACI area and number

Humeral head Glenoid

Page 35: PAIN AND SHOULDER

Material and Methods

• Dissection around pin holes• For unexpected bony lesions

Page 36: PAIN AND SHOULDER

Statistics

• Paired t test for normally distributed data• Mean ± SD

• Wilcoxon signed-rank tests for not normally distributed data• Median (interquartile range, IQR)

• Shapiro-Wilk test for normality

Page 37: PAIN AND SHOULDER

Results

Page 38: PAIN AND SHOULDER

Joint space

Joint space (IQR) 4 mm ( 1 mm) 8 mm (1.5 mm)

P value P = 0.01

Non-distraction Distraction

Page 39: PAIN AND SHOULDER

Outcome Non distraction Distraction P value

Needle time 55 (110) sec 38 (43) sec = 0.39

Probe time 215 ± 112 sec 159 ± 82 sec = 0.15

Needle time Probe Time Palpation Time

Total Surgery Time

Visualizing and palpating Intra-articular structures

Page 40: PAIN AND SHOULDER

Outcome Non distraction Distraction P value

Needle time 55 (110) sec 38 (43) sec = 0.39

Probe time 215 ± 112 sec 159 ± 82 sec = 0.15

Palpation time 138 (87) 66 (38) = 0.03*

Total surgery time 335 ± 147 sec 242 ± 88 sec = 0.01*

Needle time Probe Time Palpation Time

Total Surgery Time

Visualizing and palpating Intra-articular structures

Page 41: PAIN AND SHOULDER

IACI

Outcome Non distraction Distraction P value

IACI glenoid 3 (7.5) mm2 0 (2.3) mm2 = 0.10

IACI head 11.5 (11.8) mm2 0 (2.5) mm2 = 0.004*

IACI total number 3 (3.5) 1.5 (1) = 0.004*

IACI

Page 42: PAIN AND SHOULDER

Visibility and Palpability

• No significant difference for visibility or palpability scores for the intra-articular structures

• Higher visibility score of the supraglenoid tubercle in distraction group (P = 0.015)

Supraglenoid Tubercle

Page 43: PAIN AND SHOULDER

Results

• Leipzig distractor• 132 ± 46 seconds for placement

• No complications during the procedure

• After the procedure • No loosening of the pins

• No fracture around the pin holes

Page 44: PAIN AND SHOULDER

2. Clinical Case Series

Page 45: PAIN AND SHOULDER

Clinical Case Series

• Distracted shoulder arthroscopy in clinical cases • 9 shoulder joints with shoulder OCDs

• From 5 dogs

• Age• 8 month to 17 month year old

• Body Weight• 17 – 42 kg

• Recorded perioperative complications

• Minimal follow up of 6 weeks• At WCVM, rDVM, phone interview,

Page 46: PAIN AND SHOULDER

Clinical Case Series

• Results• Joint space increased with distraction

• Distraction device interfered visibility of caudal pouch (n=1/9)

• No perioperative complications associated with shoulder distraction

• No complications with follow up • Median 8 weeks (6-8 weeks)

Before distraction After

Page 47: PAIN AND SHOULDER

Discussion

• Distraction provided larger working joint space • Decreased IACI with distracted shoulders

• Decreased joint exploration (palpation) time

• No difference in visibility or palpability of structures• Besides supra-glenoid tubercle visibility

• Most of the structures were thoroughly visible and palpable • Without distraction

• Resulting in no significant difference between the groups

Page 48: PAIN AND SHOULDER

Discussion

• No obvious complications associated with the distractor• In vivo and ex vivo

• One clinical case experienced interference between the distractor and arthroscope

• Leipzig distractor needs to be placed cranio-lateral position than lateral

• OCD lesions were easy to manage in clinical cases • On subjective assessment

• No need for limb manipulation

Page 49: PAIN AND SHOULDER

Limitation

• Depth of the IACI not measured• Required histopathology

• Performed by a single ACVS surgeon

• Limb manipulation not performed in non-distraction group• Manipulation could improve the procedural speed

• Small sample size and no controls in the clinical case series

Page 50: PAIN AND SHOULDER

Conclusion

• Distractor decreased the area and incidence of IACI and shortened the arthroscopic time

• No major complications observed

Page 51: PAIN AND SHOULDER

Questions?

Page 52: PAIN AND SHOULDER

ALEXANDRA KALAMARAS

Page 53: PAIN AND SHOULDER

Development and Assessment of

Neuropathic Pain in Dogs after TPLO for

Cranial Cruciate Ligament Rupture

Alexandra Kalamaras, DVM, MS

ACVS 2020/2021 Webinar Series

The Ohio State University

Columbus, Ohio

Page 54: PAIN AND SHOULDER

Disclosure

• I hereby certify that, to the best of my knowledge, no aspect of

my current personal or professional situation might reasonably

be expected to significantly affect my views on the subject on

which I am presenting

• Funding provided by The Ohio State Canine Grant

Page 55: PAIN AND SHOULDER

Outline

Background

• Neuropathic Pain & Assessment

• Neuropathic Pain in Orthopedic Conditions1

Experimental Design2

Results3

Discussion

• Limitations4

Conclusions

• Clinical Relevance5

Page 56: PAIN AND SHOULDER

Background

Page 57: PAIN AND SHOULDER

Pain

• Definitions

• Pain: unpleasant sensory and emotional experience associated with actual or potential tissue damage

• Nociception: neural process of encoding noxious stimuli

• Analgesia: absence of pain in response to stimulus normally painful

• Hyperalgesia: abnormally increased sensitivity to a painful stimulus

• Allodynia: normally non-painful stimulus experienced as painful

• Hyperesthesia: non-noxious stimulus results in exaggerated and painful response

Tranquilli & Grimm 2015; Lorenz et al. 2011

Page 58: PAIN AND SHOULDER

Pain

Wiese & Yaksh 2015

Page 59: PAIN AND SHOULDER

Pain

• Nociceptive vs. Neuropathic

• Nociceptive → normal functioning somatosensory system

• Neuropathic → dysfunction somewhere along the pain pathway

• International Association for the Study of Pain (IASP)

Page 60: PAIN AND SHOULDER

Neuropathic Pain

• Definition in people:

• Pain that arises as direct consequence of lesion or disease

affecting the somatosensory system (Treede et al. 2008)

• Effects 1 in 10 adults over 30 (Yawn et al. 2010)

• Healthcare costs ~ $100 billion per year

• Huge impact on quality of life (IASP 2014)

• IASP Global Year Against Neuropathic Pain

Page 61: PAIN AND SHOULDER

Neuropathic Pain

• Underexplored in veterinary patients

• Somatosensory nervous system malfunction

• Peripheral Sensitization

• Central Sensitization

• Chronic neurologic or orthopedic injury

• Hallmarks → allodynia, hyperalgesia, and hyperesthesia

• LOWER threshold to detect a painful stimulus

Page 62: PAIN AND SHOULDER

Neuropathic Pain

Sensory Threshold (ST)

Minimum amount of stimulus that can be detected or is considered painful

(Kerns et al. 2019)

Mechanical ST

Strength of mechanical stimulus → conscious behavioral response

(Moore et al. 2013, Kerns et al. 2019)

Thermal ST

Hot/cold thermal stimulus →conscious behavioral response

(Freire et al. 2016, Knazovicky et al. 2016, Knazovicky et al. 2017)

Page 63: PAIN AND SHOULDER

Neuropathic Pain Assessment

• Von Frey Anesthesiometry (VFA)

• Quantitative evaluation of ST – evaluated in dogs

• Normal (Freire et al. 2016; Kerns et al. 2019)

• Neurologic disease (Moore et al. 2013; Song et al. 2016; Thoefner et al. 2019)

• Osteoarthritis (Freire et al. 2016; Knazovicky et al. 2016; Knozovicky et al. 2017)

Neuropathic Pain

Hyperesthesia & Hyperalgesia

Lower ST

Page 64: PAIN AND SHOULDER

Electronic Von Frey Device

Page 65: PAIN AND SHOULDER

Neuropathic Pain Assessment

• Moderate interobserver agreement (Kerns et al. 2019)

• Neurologic injury and/or disease• Higher ST - acute spinal cord injury (Moore et al. 2013)

• Differences in ST – normal vs. spinal cord injury (Song et al. 2016)

• No difference in ST – normal vs. syringomyelia (Thoefner et al. 2019)

• Osteoarthritis (OA) and degenerative joint disease (DJD)• No difference in ST - normal vs. DJD (Freire et al. 2016)

• Lower ST – osteoarthritis (Knazovicky et al. 2016)

Page 66: PAIN AND SHOULDER

Objectives

1. Assess ST in dogs before and after TPLO surgery in order to

evaluate for the development of neuropathic pain

2. Identify differences (if any) in ST among three different peri-

operative analgesic protocols for TPLO surgery in dogs

• Intravenous opioids

• Lumbosacral epidural

• Peripheral nerve blockade

Page 67: PAIN AND SHOULDER

Hypothesis

ST values 8 weeks postoperative would be lower in dogs

receiving only perioperative opioid administration, indicative of a

neuropathic pain state

Page 68: PAIN AND SHOULDER

Experimental Design

Page 69: PAIN AND SHOULDER

Study Design

• Approved by Institutional Animal Care and Use Committee

(IACUC) of The Ohio State University

• Prospective double-blinded clinical trial

• Client owned dogs with CCLR enrolled (n = 45)

• Between May 2018 and August 2019

• Procedure:

• Stifle arthroscopy

• TPLO

Page 70: PAIN AND SHOULDER

Patient Selection

• Preoperative diagnostics:

• Orthopedic and neurologic exams

• Orthopedic radiographs

• Complete blood count

• Serum biochemistry

• Urinalysis

Arthurs 2011

Page 71: PAIN AND SHOULDER

Patient Selection

Inclusion Criteria

• Diagnosed with CCLR

• Weight > 15 kg and < 60 kg

• Preoperative TPA 20º – 34º

• Temperament amenable to

handling and hospitalization

• Owner consent to 2 week and 8

week recheck visits at The OSU

Main Campus location

Exclusion Criteria

• Neurologic, systemic, or other

orthopedic disease

• Tramadol or steroids (30 days)

• Prior orthopedic surgery on

affected limb

• Conversion to arthrotomy

• Fibular fracture or implant failure

• Complication → revision surgery

Page 72: PAIN AND SHOULDER

Treatment Groups

• Three treatment groups (random assignment)

• Group 1 (MLK): n = 15

• Intravenous infusion of morphine, lidocaine & ketamine

• Group 2 (EPID): n = 15

• Lumbosacral ropivacaine & morphine epidural

• Group 3 (SSNB): n = 15

• Saphenous & sciatic nerve blockade with ropivacaine

Page 73: PAIN AND SHOULDER

Treatments

• Premedication:

• Acepromazine 0.05 mg/kg IM

• Morphine 0.2 mg/kg IM

• General anesthesia induction:

• Propofol 4 mg/kg IV to effect

• General anesthesia maintenance:

• Isoflurane in oxygen

Page 74: PAIN AND SHOULDER

Treatments

• Group 1 (MLK)

• Morphine 0.1 mg/kg/hr IV CRI

• Lidocaine 3 mg/kg/hr IV CRI

• After initial 2 mg/kg IV bolus

• Ketamine 0.6 mg/kg/hr IV CRI

• Medications in IV fluids

• Fluid bags labeled with patient #:

• (ex) Study Pt. #1

Page 75: PAIN AND SHOULDER

Treatments

• Group 2 (EPID)

• 1% ropivacaine 0.2 mg/kg

• Preservative-free morphine 0.09 mg/kg

• Lumbosacral epidural

• Every patient shaved for epidural

• Board-certified anesthesiologist

Page 76: PAIN AND SHOULDER

Treatments

• Group 3 (SSNB)

• 1% ropivacaine 2 mg/kg (each site)

• Ultrasound-guided nerve blocks

using a nerve stimulator:

• Saphenous nerve

• Sciatic nerve

• Board-certified anesthesiologistPortela, Verdier, & Otero 2018

Page 77: PAIN AND SHOULDER

Surgery

• Stifle arthroscopy

• Medial meniscal tear(s) → treated

arthroscopically

• Intact medial meniscus → left intact

• Routine TPLO surgery

• Performed by board-certified surgeon

Page 78: PAIN AND SHOULDER

Von Frey Anesthesiometry

• Evaluations:

• Preoperative

• 1 day, 2 weeks, & 8 weeks

postoperative

• 5 measurements from each

hind paw

• Highest and lowest discarded

• Average of middle 3 values

Moore et al. 2013

Page 79: PAIN AND SHOULDER

Temporospatial Gait Analysis

• Evaluations:

• Preoperative

• 1 day, 2 weeks, & 8 weeks

postoperative

• Tekscan™ Animal Walkway

System

• Data from 5 best trials

• Velocity ≥ 0.8 and ≤ 1.3 m/sec

Page 80: PAIN AND SHOULDER

Statistics

• Demographic data

• ANOVA models

• Categorical data

• Mixed effect models testing treatment effect on primary outcomes

• Kenward-Roger adjustment to degrees of freedom

• Control type I error rates

• Continuous data

• T-tests (2 variables) or ANOVA (> 2 variables)

• Two-sided significance of p<0.05

Page 81: PAIN AND SHOULDER

Results

Page 82: PAIN AND SHOULDER

CharacteristicTreatment 1

(n = 15) (MLK)

Treatment 2

(n = 15) (EPID)

Treatment 3

(n = 15) (SSNB)P-value

Weight (kg)

(mean SD)37.28 9.57 34.25 8.09 30.12 8.89 0.0975

Age (years)

(mean SD)4.93 2.15 5.2 2.57 5.33 3.24 0.9180

Sex

Female Intact

Female Spay

Male Neutered

Male Intact

0

7

8

0

2

5

7

1

0

8

7

0

0.5121

Surgical Limb

Left

Right

9

6

8

7

9

60.9999

Completeness of Tear

Full

Partial

11

4

9

6

13

2

0.3156

Current Bilateral CCLR

Yes

No

4

11

3

12

4

110.9999

Meniscal Status

Intact

Torn

7

8

9

6

9

60.8039

Page 83: PAIN AND SHOULDER

Results

• Sensory Threshold

• Lower for surgical limb

(p < 0.0001)

• No difference among

treatment groups250

300

350

400

450

500

550

Preop Postop 2 Weeks 8 Weeks

Sensory Threshold (Average)

Epidural + Other Epidural + Surgical

Saphenous Sciatic + Other Saphenous Sciatic + Surgical

MLK + Other MLK + Surgical

Page 84: PAIN AND SHOULDER

Results

• No difference among treatment groups

• Anesthesia duration (p = 0.8140)

• Temporospatial gait analysis

• Surgery duration not affected by surgeon (p = 0.8350)

Page 85: PAIN AND SHOULDER

Discussion

Page 86: PAIN AND SHOULDER

Discussion

Hypothesis rejected:

• No difference in ST among treatment groups

Page 87: PAIN AND SHOULDER

Discussion

• ST lower in surgical limb

• Expected finding

• No difference in ST among treatment groups

• Even when ST scaled to body weight

• Discussed by Moore et al. 2013

• OA associated with lower ST (Knazovicky et al. 2016)

• Current study did not evaluate severity of OA

• May have missed an essential variable with regards to ST

Page 88: PAIN AND SHOULDER

Limitations

• Low number of patients

• Type I error

• ST Data

• 8 weeks may not be enough time for neuropathic pain development

• No assessment of osteoarthritis (radiographically)

• Variability between surgeons or anesthesiologists

Page 89: PAIN AND SHOULDER

Conclusion

Page 90: PAIN AND SHOULDER

Conclusion

• No significant change in sensory threshold over time

• Unable to show a difference in neuropathic pain state development

• Sensory threshold values consistently lower in surgical limb

Page 91: PAIN AND SHOULDER

Acknowledgements

• Nina R. Kieves, DVM, DACVS-SA, DACVSMR, CCRT

• Sarah Moore, DVM, DACVIM (Neurology)

• Turi Aarnes, DVM, MS, DACVAA

• Carolina Ricco Pereira, DVM, MS, DACVAA

• Stephen C. Jones, MVB, MS, DACVS-SA

• James Howard, DVM, MS, DACVS-SA

• Juan Peng, MAS

Page 92: PAIN AND SHOULDER

Thank You!

Page 93: PAIN AND SHOULDER

References

• Aguado D, Benito J, Gomez de Segura IA (2011) Reduction of the minimum alveolar concentration of isoflurane in dogs using a constant rate of infusion of lidocaine-ketamine in combination with either morphine or fentanyl. Vet J 189, 63-66.

• Bartel AKG, Campoy L, Martin-Flores M et al. (2016) Comparison of bupivacaine and dexmedetomidine femoral and sciatic nerve blocks with bupivacaine and buprenorphine epidural injection for stifle arthroplasty in dogs. Vet AnesthAnalg 43, 435-443.

• Boscan P, Wennogle S (2016) Evaluating femoral-sciatic nerve blocks, epidural analgesia, and no use of regional analgesia in dogs undergoing tibia-plateau leveling-osteotomy. J Am Anim Hosp Assoc 52, 102-108.

• Campoy L, Martin-Flores M, Ludders JW et al. (2012) Comparison of bupivacaine femoral and sciatic nerve block versus bupivacaine and morphine epidural for stifle surgery in dogs. Vet Anaesth Analg 39, 91-98.

• Caniglia AM, Driessen B, Pureto DA et al. (2012) Intraoperative antinociception and postoperative analgesia following epidural anesthesia versus femoral and sciatic nerve blockade in dogs undergoing stifle joint surgery. J Am Vet Med Assoc 241, 1605-1612.

• Conzemius MG, Hill CM, Sammarco JL et al. (1997) Correlation between subjective and objective measures used to determine severity of postoperative pain in dogs. J Am Vet Med Assoc 210, 1619-1622.

• Drygas KA, McClure SR, Goring RL et al. (2011) Effect of cold compression therapy on postoperative pain, swelling, range of motion, and lameness after tibial plateau leveling osteotomy in dogs. J Am Vet Med Assoc 238, 1284-1291.

• Duerr FM, Martin KW, Rishniw M et al. (2014) Treatment of canine cranial cruciate ligament disease. Vet Comp OrthopTraumatol 27, 478-483.

Page 94: PAIN AND SHOULDER

References

• Ebner LS, Lerche P, Bednarski RM et al. (2013) Effect of dexmedetomidine, morphine-lidocaine-ketamine, and dexmedetomidine-morphine-lidocaine-ketamine constant rate infusions on the minimum alveolar concentration of isoflurane and bispectral index in dogs. Am J Vet Res 74, 963-970.

• Gurney MA, Leece EA (2014) Analgesia for pelvic limb surgery. A review of peripheral nerve blocks and the extradural technique. Vet Anaesth Analg 41, 445-458.

• Hoelzler MB, Harvey RC, Lidbetter DA et al. (2005) Comparison of perioperative analgesic protocols of dogs undergoing tibial plateau leveling osteotomy. Vet Surg 34, 337-344.

• Hofmeister EH, Chandler MJ, Read MR (2010) Effects of acepromazine, hydromorphone, or acepromazine-hydromorphone combination on the degree of sedation in clinically normal dogs. J Am Vet Med Assoc 237, 1155-1159.

• Hofmeister EH, Egger CM (2005) Evaluation of diphenhydramine as a sedative for dogs. J Am Vet Med Assoc 226, 1092-1094.

• Holton LL, Scott EM, Nolan AM et al (1998) Comparison of three methods used for assessment of pain in dogs. J Am Vet Med Assoc 212, 61-66

• Jones RS (2001) Epidural analgesia in the dog and cat. Vet J 161, 123-131.

• Knazovicky D, Helgeson ES, Case B et al. (2016) Widespread somatosensory sensitivity in naturally occurring canine model of osteoarthritis. Pain 157, 1325-1332.

• KuKanich B, Wiese AJ (2015) Opioids. Chapter in Veterinary Anesthesia and Analgesia (5th edition)

Page 95: PAIN AND SHOULDER

References

• Lewis KA, Bednarski RM, Aarnes TK et al. (2014) Postoperative comparison of four perioperative analgesia protocols in dogs undergoing stifle joint surgery. J Am Vet Med Assoc 244, 1041-1046.

• Lorenz M, Coates J, Kent M (2011) Pain. Chapter in Handbook of Veterinary Neurology (5th edition)

• McCally RE, Bukoski A, Branson KR et al. (2015) Comparison of short-term postoperative analgesia by epidural, femoral nerve block, or combination femoral and sciatic nerve block in dogs undergoing tibial plateau leveling osteotomy. Vet Surg 44, 983-987.

• Mich PM, Hellyer PW, Kogan L et al. (2010) Effects of a pilot training program on veterinary students’ pain knowledge, attitude, and assessment skills. J Vet Med Educ 37, 358-368.

• Muir III WW, Wiese AJ, March PA et al. (2003) Effects of morphine, lidocaine, ketamine, and morphine-lidocaine-ketamine drug combination on minimum alveolar concentration in dogs anesthetized with isoflurane. Am J Vet Res 64, 1155-1160.

• Murrell JC, Psatha EP, Scott EM et al. (2008) Application of a modified form of the Glasgow pain scale in a veterinary teaching centre in the Netherlands. Vet Rec 162, 403-408.

• Palomba N, Vettorato E, De Gennaro C et al. (2019) Peripheral nerve block versus systemic analgesia in dogs undergoing tibial plateau levelling osteotomy: Analgesic efficacy and pharmacoeconomics comparison. Vet AnaesthAnalg, 47, 119-128.

• Portela DA, Verdier N, Otero PE (2018) Regional anesthetic techniques for the pelvic limb and abdominal wall in small animals: A review of the literature and technique description. Vet J 238, 27-40.

Page 96: PAIN AND SHOULDER

References

• Reid J, Nolan AM, Hughes JML et al. (2007) Development of the short-form Glasgow Composite Measure Pain Scale (CMPS-SF) and derivation of an analgesic intervention score. Anim Welf 16, 97-104.

• Smith LJ, Yu JKA, Bjorling ED et al. (2001) Effects of hydromorphone or oxymorphone, with or without acepromazine, on preanesthetic sedation, physiologic values, and histamine release in dogs. J Am Vet Med Assoc 218, 1101-1105.

• Tomas A, Bledsoe D, Wall S et al. (2015) Initial evaluation of a canine stifle arthrotomy post-operative pain model. Vet J 204, 293-298.

• Tranquilli WJ, Grimm KA (2015) Introduction: Use, definitions, history, concepts, classification, and considerations for anesthesia and analgesia. Veterinary Anesthesia and Analgesia (5th edition)

• Treede RD, Jensen TS, Campbell JN (2008) Neuropathic pain: redefinition and a grading system for clinical and research purposes. Neuro 70, 1630-1635.

• Wagner MC, Hecker KG, Pang DSJ (2017) Sedation levels in dogs: a validation study. BMC Vet Res 13, 110.

• Wendlund TM, Martin KW, Duncan CG et al. (2016) Evaluation of pacing as an indicator of musculoskeletal pathology in dogs. J Vet Med Anim Health 8, 207–213.

• Wiese AJ, Yaksh TL (2015) Nociception and Pain Mechanisms. Chapter in Handbook of Veterinary Pain Management (3rd edition)

Page 97: PAIN AND SHOULDER

ALEXANDRA KALAMARAS

Page 98: PAIN AND SHOULDER

Effect of Analgesic Protocols on

Postoperative Pain in Dogs after TPLO

for Cranial Cruciate Ligament Rupture

Alexandra Kalamaras, DVM, MS

ACVS 2020/2021 Webinar Series

The Ohio State University

Columbus, Ohio

Page 99: PAIN AND SHOULDER

Disclosure

• I hereby certify that, to the best of my knowledge, no aspect of

my current personal or professional situation might reasonably

be expected to significantly affect my views on the subject on

which I am presenting

• Funding provided by The Ohio State Canine Grant

Page 100: PAIN AND SHOULDER

Outline

Background

• Pain Perception & Assessment

• TPLO Analgesia1

Experimental Design2

Results3

Discussion

• Limitations4

Conclusions

• Clinical Relevance5

Page 101: PAIN AND SHOULDER

Background

Page 102: PAIN AND SHOULDER

Pain Assessment

• Methods for assessment of post-operative pain

• Simple descriptive scales (SDS)

• Visual analog scale (VAS)

• Numerical rating scale (NRS)

• Multifactorial pain scales (MFPS)

• Behavior-based composite scales

• Colorado State University Canine Acute Pain Scale (CSU-CAPS) (Mich et al. 2010)

• Glasgow Composite Measure Pain Scale – short form (CMPS-SF) (Holton et al. 2001, Morton et al. 2005, Reid et al. 2007)

Page 103: PAIN AND SHOULDER

Pain Assessment

• Methods for assessment of post-operative pain

• Simple descriptive scales (SDS)

• Visual analog scale (VAS)

• Numerical rating scale (NRS)

• Multifactorial pain scales (MFPS)

• Behavior-based composite scales

• Colorado State University Canine Acute Pain Scale (CSU-CAPS) (Mich et al. 2010)

• Glasgow Composite Measure Pain Scale – short form (CMPS-SF) (Holton et al. 2001, Morton et al. 2005, Reid et al. 2007)

Page 104: PAIN AND SHOULDER

Pain Assessment

• Methods for assessment of post-operative pain

• Simple descriptive scales (SDS)

• Visual analog scale (VAS)

• Numerical rating scale (NRS)

• Multifactorial pain scales (MFPS)

• Behavior-based composite scales

• Colorado State University Canine Acute Pain Scale (CSU-CAPS) (Mich et al. 2010)

• Glasgow Composite Measure Pain Scale – short form (CMPS-SF) (Holton et al. 2001, Morton et al. 2005, Reid et al. 2007)

Conzemius et al. 1997

Page 105: PAIN AND SHOULDER

Minimal

Mild

Mild to Moderate

Reassessanalgesic plan

Moderate

Reassessanalgesic plan

Moderate toSevere

May be rigid toavoid painful

movement

Reassessanalgesic plan

Pain Score Psychological & BehavioralExample Response to Palpation Body Tension

Comments

© 2006/PW Hellyer, SR Uhrig, NG Robinson

Colorado State University

Veterinary Medical Center

Canine Acute Pain Scale

Date

Time

Tender to palpation

Warm

Tense

Rescore when awake

Supported by an Unrestricted Educational Grant from Pfizer Animal Health

1

2

3

4

0Comfortable when resting

Happy, content

Not bothering wound or surgery site

Interested in or curious about surroundings

Content to slightly unsettled or restless

Distracted easily by surroundings

Looks uncomfortable when resting

May whimper or cry and may lick or rub

wound or surgery site when unattended

Droopy ears, worried facial expression

(arched eye brows, darting eyes)

Reluctant to respond when beckoned

Not eager to interact with people or surroundings

but will look around to see what is going on

Unsettled, crying, groaning, biting or

chewing wound when unattended

Guards or protects wound or surgery site by

altering weight distribution (i.e., limping,

shifting body position)

May be unwilling to move all or part of body

Constantly groaning or screaming when

unattended

May bite or chew at wound, but unlikely to

move

Potentially unresponsive to surroundings

Difficult to distract from pain

Cries at non-painful palpation

(may be experiencing allodynia,

wind-up, or fearful that pain

could be made worse)

May react aggressively to palpation

May be subtle (shifting eyes or

increased respiratory rate) if dog

is too painful to move or is stoic

May be dramatic, such as a

sharp cry, growl, bite or bite

threat, and/or pulling away

Reacts to palpation of wound,

surgery site, or other body part

by looking around, flinching, or

whimpering

Flinches, whimpers cries, or

guards/pulls away

Nontender to palpation of

wound or surgery site, or to

palpation elsewhere

Animal is sleeping, but can be aroused - Not evaluated for pain

Animal can’t be aroused, check vital signs, assess therapy

RIGHT LEFT

Pain Assessment

• Methods for assessment of post-operative pain

• Simple descriptive scales (SDS)

• Visual analog scale (VAS)

• Numerical rating scale (NRS)

• Multifactorial pain scales (MFPS)

• Behavior-based composite scales

• Colorado State University Canine Acute Pain Scale (CSU-CAPS) (Mich et al. 2010)

• Glasgow Composite Measure Pain Scale – short form (CMPS-SF) (Holton et al. 2001, Morton et al. 2005, Reid et al. 2007)

Page 106: PAIN AND SHOULDER

Cranial Cruciate Ligament Rupture

• Spontaneous cranial cruciate

ligament (CCL) rupture

common in dogs

• Tibial plateau leveling

osteotomy (TPLO) → stabilize

stifle by altering tibial plateau

angle (TPA)

Evans & de Lahunta 2013

Page 107: PAIN AND SHOULDER

TPLO Perioperative Analgesia

• No gold standard perioperative

analgesic protocol

• Commonly reported options:

• Intravenous opioids

• Lumbosacral epidural analgesia

• Peripheral nerve blockade

Guedes 2011

Portela, Verdier, & Otero 2018

Page 108: PAIN AND SHOULDER

Perioperative Analgesia

• Peripheral nerve block vs. intravenous opioids• Peripheral nerve block superior (Palomba et al. 2019)

• Peripheral nerve block vs. epidural • Epidural – more rescue opioids, urine retention (Campoy et al. 2012)

• No difference (Caniglia et al. 2012; McCally et al. 2015; Bartel et al. 2016)

• Intravenous opioids vs. epidural• No difference (Lewis et al. 2014)

• Intravenous opioids vs. epidural vs. peripheral nerve block• No difference (Boscan & Wennogle 2016)

Page 109: PAIN AND SHOULDER

Objectives

1. Evaluate efficacy of three different analgesic protocols for

TPLO surgery in dogs

2. Identify superior and/or inferior protocols, if any, for immediate

postoperative pain control

3. Assess sedation levels associated with three different

analgesic protocols for TPLO surgery in dogs

Page 110: PAIN AND SHOULDER

Hypotheses

1. Lumbosacral epidural analgesia and saphenous/sciatic nerve

blockade would provide superior analgesia compared to

intravenous opioids (demonstrated by lower pain scores)

2. Intravenous opioids would cause more sedation than

lumbosacral epidural analgesia and saphenous/sciatic nerve

blockade (demonstrated by higher sedation scores)

Page 111: PAIN AND SHOULDER

Experimental Design

Page 112: PAIN AND SHOULDER

Study Design

• Approved by Institutional Animal Care and Use Committee

(IACUC) of The Ohio State University

• Prospective double-blinded clinical trial

• Client owned dogs with CCLR enrolled (n = 45)

• Between May 2018 and August 2019

• Procedure:

• Stifle arthroscopy

• TPLO

Page 113: PAIN AND SHOULDER

Patient Selection

• Preoperative diagnostics:

• Orthopedic and neurologic exams

• Orthopedic radiographs

• Complete blood count

• Serum biochemistry

• Urinalysis

Arthurs 2011

Page 114: PAIN AND SHOULDER

Patient Selection

Inclusion Criteria

• Diagnosed with CCLR

• Weight > 15 kg and < 60 kg

• Preoperative TPA 20º – 34º

• Temperament amenable to

handling and hospitalization

• Owner consent to 2 week and 8

week recheck visits at The OSU

Main Campus location

Exclusion Criteria

• Neurologic, systemic, or other

orthopedic disease

• Tramadol or steroids (30 days)

• Prior orthopedic surgery on

affected limb

• Conversion to arthrotomy

• Fibular fracture or implant failure

• Complication → revision surgery

Page 115: PAIN AND SHOULDER

Treatment Groups

• Three treatment groups (random assignment)

• Group 1 (MLK): n = 15

• Intravenous infusion of morphine, lidocaine & ketamine

• Group 2 (EPID): n = 15

• Lumbosacral ropivacaine & morphine epidural

• Group 3 (SSNB): n = 15

• Saphenous & sciatic nerve blockade with ropivacaine

Page 116: PAIN AND SHOULDER

Treatments

• Premedication:

• Acepromazine 0.05 mg/kg IM

• Morphine 0.2 mg/kg IM

• General anesthesia induction:

• Propofol 4 mg/kg IV to effect

• General anesthesia maintenance:

• Isoflurane in oxygen

Page 117: PAIN AND SHOULDER

Treatments

• Group 1 (MLK)

• Morphine 0.1 mg/kg/hr IV CRI

• Lidocaine 3 mg/kg/hr IV CRI

• After initial 2 mg/kg IV bolus

• Ketamine 0.6 mg/kg/hr IV CRI

• Medications in IV fluids

• Fluid bags labeled with patient #:

• (ex) Study Pt. #1

Page 118: PAIN AND SHOULDER

Treatments

• Group 2 (EPID)

• 1% ropivacaine 0.2 mg/kg

• Preservative-free morphine 0.09 mg/kg

• Lumbosacral epidural

• Every patient shaved for epidural

• Board-certified anesthesiologist

Page 119: PAIN AND SHOULDER

Treatments

• Group 3 (SSNB)

• 1% ropivacaine 2 mg/kg (each site)

• Ultrasound-guided nerve blocks

using a nerve stimulator:

• Saphenous nerve

• Sciatic nerve

• Board-certified anesthesiologistPortela, Verdier, & Otero 2018

Page 120: PAIN AND SHOULDER

Surgery

• Stifle arthroscopy

• Medial meniscal tear(s) → treated

arthroscopically

• Intact medial meniscus → left intact

• Routine TPLO surgery

• Performed by board-certified surgeon

Page 121: PAIN AND SHOULDER

Postoperative Monitoring

24 Hours Postoperative

• 0 hour (AK or NRK)

• Extubation

• 2 hours (AK)

• 4 hours (AK)

• 8 hours (AK)

• 24 hours (AK)

Assessments

• Sedation score

• Pain scores

• CSU-CAPS

• CMPS-SF

• Pain scores only if

sedation score ≤ 10

Rescue analgesia if CMPS-SF > 5

(morphine 0.4 mg/kg IM)

Page 122: PAIN AND SHOULDER

Postoperative Monitoring

• Sedation scores

• One of two observers (NK or AK)

Hofmeister, Chandler & Read 2010

Page 123: PAIN AND SHOULDER

Pain Score

• Pain scores• CSU-CAPS

• CMPS-SF

• One observer (AK)

Page 124: PAIN AND SHOULDER

Statistics

• Demographic data

• ANOVA models

• Categorical data

• Mixed effect models testing treatment effect on primary outcomes

• Kenward-Roger adjustment to degrees of freedom

• Control type I error rates

• Continuous data

• T-tests (2 variables) or ANOVA (> 2 variables)

• Two-sided significance of p<0.05

Page 125: PAIN AND SHOULDER

Results

Page 126: PAIN AND SHOULDER

CharacteristicTreatment 1

(n = 15) (MLK)

Treatment 2

(n = 15) (EPID)

Treatment 3

(n = 15) (SSNB)P-value

Weight (kg)

(mean SD)37.28 9.57 34.25 8.09 30.12 8.89 0.0975

Age (years)

(mean SD)4.93 2.15 5.2 2.57 5.33 3.24 0.9180

Sex

Female Intact

Female Spay

Male Neutered

Male Intact

0

7

8

0

2

5

7

1

0

8

7

0

0.5121

Surgical Limb

Left

Right

9

6

8

7

9

60.9999

Completeness of Tear

Full

Partial

11

4

9

6

13

2

0.3156

Current Bilateral CCLR

Yes

No

4

11

3

12

4

110.9999

Meniscal Status

Intact

Torn

7

8

9

6

9

60.8039

Page 127: PAIN AND SHOULDER

Results

• Sedation scores:

• Higher for MLK compared to

EPID and SSNB (p=0.0098)

• All decreased to 0 by 24-hour

time point0

2

4

6

8

10

12

14

0 2 4 8 24

Sedation Score

Epidural Saphenous Sciatic MLK

Page 128: PAIN AND SHOULDER

Results

• Pain scores:

• Lower for SSNB compared to

EPID and MLK

• CSU-CAPS (p = 0.0139)

• CMPS-SF (p = 0.0024)

• No rescue analgesia needed

0

0.2

0.4

0.6

0.8

1

2 4 8 24

CSU-CAPS Score

Epidural Saphenous Sciatic MLK

0

1

2

3

4

5

2 4 8 24

CMPS-SF Score

Epidural Saphenous Sciatic MLK

Page 129: PAIN AND SHOULDER

Results

• No difference among groups for anesthesia duration

(p = 0.8140)

• Surgical procedure duration not affected by surgeon

(p = 0.8350)

Page 130: PAIN AND SHOULDER

Discussion

Page 131: PAIN AND SHOULDER

Discussion

• First hypothesis rejected:

• Lower pain scores for SSNB (CSU-CAPS & CMPS-SF)

• No difference between MLK and EPID

• Second hypothesis accepted:

• Higher sedation score for MLK

Page 132: PAIN AND SHOULDER

Discussion

• SSNB → superior analgesia• Similar:

• Campoy et al. 2012

• Palomba et al. 2019

• Contradicting:

• Caniglia et al. 2012

• McCally et al. 2015

• Bartel et al. 2016

• Boscan & Wennogle 2016

• No rescue analgesia for any patient

• Adequate postoperative pain management for each group

Differences:

• Medications

• Dose

• Assessment

Page 133: PAIN AND SHOULDER

Discussion

• MLK → higher sedation scores

• Similar: Campoy et al. 2012

• Contradicting: Lewis et al. 2014

• MLK decreases isoflurane minimum alveolar concentration

(MAC) (Muir et al. 2003; Aguado et al. 2011; Ebner et al. 2013 )

• Current study → did not measure end-tidal isoflurane

• MLK patients may have received isoflurane > MAC

• Consider alternative to MLK if patient discharge same day

Page 134: PAIN AND SHOULDER

Discussion

• No difference in anesthesia time

• Similar:

• Campoy et al. 2012

• McCally et al. 2015

• Palomba et al. 2019

• Lewis et al. 2014

• Boscan & Wennogle 2016

• Anesthesia duration should not be a factor in deciding between

perioperative analgesic protocols

Page 135: PAIN AND SHOULDER

Limitations

• Low number of patients

• Type I error

• Variability between surgeons or anesthesiologists

• Intraoperative monitoring parameters not evaluated

Page 136: PAIN AND SHOULDER

Conclusion

Page 137: PAIN AND SHOULDER

Conclusion

• All protocols provided adequate post-operative pain management

• Improved pain scores with SSNB

• SSNB and EPID did not prolong anesthesia duration

• Higher sedation scores with perioperative intravenous MLK

• Consider in situations when higher sedation contraindicated

Page 138: PAIN AND SHOULDER

Acknowledgements

• Nina R. Kieves, DVM, DACVS-SA, DACVSMR, CCRT

• Sarah Moore, DVM, DACVIM (Neurology)

• Turi Aarnes, DVM, MS, DACVAA

• Carolina Ricco Pereira, DVM, MS, DACVAA

• Stephen C. Jones, MVB, MS, DACVS-SA

• James Howard, DVM, MS, DACVS-SA

• Juan Peng, MAS

Page 139: PAIN AND SHOULDER

Thank You!

Page 140: PAIN AND SHOULDER

References

• Aguado D, Benito J, Gomez de Segura IA (2011) Reduction of the minimum alveolar concentration of isoflurane in dogs using a constant rate of infusion of lidocaine-ketamine in combination with either morphine or fentanyl. Vet J 189, 63-66.

• Bartel AKG, Campoy L, Martin-Flores M et al. (2016) Comparison of bupivacaine and dexmedetomidine femoral and sciatic nerve blocks with bupivacaine and buprenorphine epidural injection for stifle arthroplasty in dogs. Vet AnesthAnalg 43, 435-443.

• Boscan P, Wennogle S (2016) Evaluating femoral-sciatic nerve blocks, epidural analgesia, and no use of regional analgesia in dogs undergoing tibia-plateau leveling-osteotomy. J Am Anim Hosp Assoc 52, 102-108.

• Campoy L, Martin-Flores M, Ludders JW et al. (2012) Comparison of bupivacaine femoral and sciatic nerve block versus bupivacaine and morphine epidural for stifle surgery in dogs. Vet Anaesth Analg 39, 91-98.

• Caniglia AM, Driessen B, Pureto DA et al. (2012) Intraoperative antinociception and postoperative analgesia following epidural anesthesia versus femoral and sciatic nerve blockade in dogs undergoing stifle joint surgery. J Am Vet Med Assoc 241, 1605-1612.

• Conzemius MG, Hill CM, Sammarco JL et al. (1997) Correlation between subjective and objective measures used to determine severity of postoperative pain in dogs. J Am Vet Med Assoc 210, 1619-1622.

• Drygas KA, McClure SR, Goring RL et al. (2011) Effect of cold compression therapy on postoperative pain, swelling, range of motion, and lameness after tibial plateau leveling osteotomy in dogs. J Am Vet Med Assoc 238, 1284-1291.

• Duerr FM, Martin KW, Rishniw M et al. (2014) Treatment of canine cranial cruciate ligament disease. Vet Comp OrthopTraumatol 27, 478-483.

Page 141: PAIN AND SHOULDER

References

• Ebner LS, Lerche P, Bednarski RM et al. (2013) Effect of dexmedetomidine, morphine-lidocaine-ketamine, and dexmedetomidine-morphine-lidocaine-ketamine constant rate infusions on the minimum alveolar concentration of isoflurane and bispectral index in dogs. Am J Vet Res 74, 963-970.

• Gurney MA, Leece EA (2014) Analgesia for pelvic limb surgery. A review of peripheral nerve blocks and the extradural technique. Vet Anaesth Analg 41, 445-458.

• Hoelzler MB, Harvey RC, Lidbetter DA et al. (2005) Comparison of perioperative analgesic protocols of dogs undergoing tibial plateau leveling osteotomy. Vet Surg 34, 337-344.

• Hofmeister EH, Chandler MJ, Read MR (2010) Effects of acepromazine, hydromorphone, or acepromazine-hydromorphone combination on the degree of sedation in clinically normal dogs. J Am Vet Med Assoc 237, 1155-1159.

• Hofmeister EH, Egger CM (2005) Evaluation of diphenhydramine as a sedative for dogs. J Am Vet Med Assoc 226, 1092-1094.

• Holton LL, Scott EM, Nolan AM et al (1998) Comparison of three methods used for assessment of pain in dogs. J Am Vet Med Assoc 212, 61-66

• Jones RS (2001) Epidural analgesia in the dog and cat. Vet J 161, 123-131.

• Knazovicky D, Helgeson ES, Case B et al. (2016) Widespread somatosensory sensitivity in naturally occurring canine model of osteoarthritis. Pain 157, 1325-1332.

• KuKanich B, Wiese AJ (2015) Opioids. Chapter in Veterinary Anesthesia and Analgesia (5th edition)

Page 142: PAIN AND SHOULDER

References

• Lewis KA, Bednarski RM, Aarnes TK et al. (2014) Postoperative comparison of four perioperative analgesia protocols in dogs undergoing stifle joint surgery. J Am Vet Med Assoc 244, 1041-1046.

• Lorenz M, Coates J, Kent M (2011) Pain. Chapter in Handbook of Veterinary Neurology (5th edition)

• McCally RE, Bukoski A, Branson KR et al. (2015) Comparison of short-term postoperative analgesia by epidural, femoral nerve block, or combination femoral and sciatic nerve block in dogs undergoing tibial plateau leveling osteotomy. Vet Surg 44, 983-987.

• Mich PM, Hellyer PW, Kogan L et al. (2010) Effects of a pilot training program on veterinary students’ pain knowledge, attitude, and assessment skills. J Vet Med Educ 37, 358-368.

• Muir III WW, Wiese AJ, March PA et al. (2003) Effects of morphine, lidocaine, ketamine, and morphine-lidocaine-ketamine drug combination on minimum alveolar concentration in dogs anesthetized with isoflurane. Am J Vet Res 64, 1155-1160.

• Murrell JC, Psatha EP, Scott EM et al. (2008) Application of a modified form of the Glasgow pain scale in a veterinary teaching centre in the Netherlands. Vet Rec 162, 403-408.

• Palomba N, Vettorato E, De Gennaro C et al. (2019) Peripheral nerve block versus systemic analgesia in dogs undergoing tibial plateau levelling osteotomy: Analgesic efficacy and pharmacoeconomics comparison. Vet AnaesthAnalg, 47, 119-128.

• Portela DA, Verdier N, Otero PE (2018) Regional anesthetic techniques for the pelvic limb and abdominal wall in small animals: A review of the literature and technique description. Vet J 238, 27-40.

Page 143: PAIN AND SHOULDER

References

• Reid J, Nolan AM, Hughes JML et al. (2007) Development of the short-form Glasgow Composite Measure Pain Scale (CMPS-SF) and derivation of an analgesic intervention score. Anim Welf 16, 97-104.

• Smith LJ, Yu JKA, Bjorling ED et al. (2001) Effects of hydromorphone or oxymorphone, with or without acepromazine, on preanesthetic sedation, physiologic values, and histamine release in dogs. J Am Vet Med Assoc 218, 1101-1105.

• Tomas A, Bledsoe D, Wall S et al. (2015) Initial evaluation of a canine stifle arthrotomy post-operative pain model. Vet J 204, 293-298.

• Tranquilli WJ, Grimm KA (2015) Introduction: Use, definitions, history, concepts, classification, and considerations for anesthesia and analgesia. Veterinary Anesthesia and Analgesia (5th edition)

• Treede RD, Jensen TS, Campbell JN (2008) Neuropathic pain: redefinition and a grading system for clinical and research purposes. Neuro 70, 1630-1635.

• Wagner MC, Hecker KG, Pang DSJ (2017) Sedation levels in dogs: a validation study. BMC Vet Res 13, 110.

• Wendlund TM, Martin KW, Duncan CG et al. (2016) Evaluation of pacing as an indicator of musculoskeletal pathology in dogs. J Vet Med Anim Health 8, 207–213.

• Wiese AJ, Yaksh TL (2015) Nociception and Pain Mechanisms. Chapter in Handbook of Veterinary Pain Management (3rd edition)

Page 144: PAIN AND SHOULDER

SAM CHIU

Page 145: PAIN AND SHOULDER

The Effect of Meloxicam on Conditioned

Pain Modulation in the Canine Model

Sam Chiu (2nd Year Resident)

Jon Hash, Rachel C. Meyers, B. Duncan X. Lascelles

Page 146: PAIN AND SHOULDER

Conflicts of Interest

• I hereby certify that, to the best of my knowledge, no

aspect of my current legal, personal or professional

situation might reasonably be expected to affect my

views on the subject on which I am presenting, other than

the following:

– Boehringer Ingelheim provided funding for this study

– B. Duncan X. Lascelles is a BI consultant

Page 147: PAIN AND SHOULDER

18 Million

Page 148: PAIN AND SHOULDER

80%

20%

Response to most analgesics in patients with osteoarthritis

Clinically Unsuccessful

Osteoarthritis pain control

Schnitzer TJ et al Osteoarthritis Cartilage 2015

Page 149: PAIN AND SHOULDER

Push towards Precision Medicine

Edwards RR et al Pain 2016

Page 150: PAIN AND SHOULDER

Biomarker

Disease subtype

Demographics

Risk Profiles

Clinical Features

Page 151: PAIN AND SHOULDER

Biomarker

Disease subtype

Demographics

Risk Profiles

Clinical Features

Page 152: PAIN AND SHOULDER

Biomarker

Disease subtype

Demographics

Risk Profiles

Clinical Features

Page 153: PAIN AND SHOULDER
Page 154: PAIN AND SHOULDER

Central Sensitization (CS)

Peripheral Sensitization (PS) EAS

Impairment

Page 155: PAIN AND SHOULDER

Central Sensitization (CS)

Peripheral Sensitization (PS) EAS

Impairment

Page 156: PAIN AND SHOULDER

Central Sensitization (CS)

Peripheral Sensitization (PS) EAS

Impairment

Page 157: PAIN AND SHOULDER

Central Sensitization (CS)

Peripheral Sensitization (PS) EAS

Impairment

Page 158: PAIN AND SHOULDER

EndogenousAnalgesic System

Page 159: PAIN AND SHOULDER

EASImpairment

Page 160: PAIN AND SHOULDER

Clinical Significance

• OA Dogs may have central/peripheral sensitization and EAS

impairment

Chiu KW et al Sci Rep 2020

Novick D et al Pain 2016

Page 161: PAIN AND SHOULDER

Clinical Significance

• OA Dogs may have central/peripheral sensitization and EAS

impairment

• Surgical perspective: Canine total hip replacement patients do not

have central sensitization reversal till 12 months post-op

Tomas A et al Vet Surg 2014

Page 162: PAIN AND SHOULDER

VAS

Conditioned Pain Modulation (CPM) paradigm

Page 163: PAIN AND SHOULDER

Endogenous analgesic system

Osteoarthritis

Page 164: PAIN AND SHOULDER

Endogenous analgesic system

Increased

pain

Page 165: PAIN AND SHOULDER

Process of Predicting Analgesic Efficacy

Phenotype Administer AnalgesicAnalyze Pain Alleviation

based on Phenotype

Page 166: PAIN AND SHOULDER

Process of Predicting Analgesic Efficacy

Phenotype Administer AnalgesicAnalyze Pain Alleviation

based on Phenotype

Apply Algorithm to Predict Analgesic

Response

Page 167: PAIN AND SHOULDER

Aim of study

• To evaluate the ability of an NSAID to reverse EPM

impairment in dogs with osteoarthritis

Page 168: PAIN AND SHOULDER

MethodsPlacebo-controlled double-blinded cross-over clinical study

• Subjects: 45 OA dogs with evidence of chronic pain

• Inclusion criteria:

– >1 year old with >6 months history of chronic pain

– Showing signs of stifle or hip pain without evidence of other

systematic disease (e.g. neurological deficits)

– High pain score based on validated client questionnaires

Page 169: PAIN AND SHOULDER

Methods: Timeline

Screening

Randomize Day 0

(Visit 1)

Day 28

(Visit 2)

Washout

Day 42

(Visit 3)

Day 70

(Visit 4)

Group A Placebo NSAID

Group B NSAID Placebo

Page 170: PAIN AND SHOULDER

Methods: Timeline

Screening

Randomize Day 0

(Visit 1)

Day 28

(Visit 2)

Washout

Day 42

(Visit 3)

Day 70

(Visit 4)

Group A Placebo NSAID

Group B NSAID Placebo

Page 171: PAIN AND SHOULDER

Methods: Timeline

Screening

Randomize Day 0

(Visit 1)

Day 28

(Visit 2)

Washout

Day 42

(Visit 3)

Day 70

(Visit 4)

Group A Placebo NSAID

Group B NSAID Placebo

Page 172: PAIN AND SHOULDER

Step 1 Step 2 Step 3

Pre-conditioning Mech/Hot test

stimulus

Post-conditioning Mech/Hot test

stimulus

22N mechanical Conditioning

stimulus (2 minutes)

Conditioning stimulus continued

Methods: Conditioned Pain Modulation Testing

Page 173: PAIN AND SHOULDER

Methods: Conditioned Pain Modulation Testing

Step 1 Step 2 Step 3

Pre-conditioning Mech/Hot test

stimulus

Post-conditioning Mech/Hot test

stimulus

22N mechanical Conditioning

stimulus (2 minutes)

Conditioning stimulus continued

Page 174: PAIN AND SHOULDER

• Step 1: Apply test stimulus (5 trials)

Mechanical stimulusThermal stimulus

49˚C

Methods: Conditioned Pain Modulation Testing

Page 175: PAIN AND SHOULDER

Mechanical Quantitative Sensory Testing

Page 176: PAIN AND SHOULDER

Step 1 Step 2 Step 3

Pre-conditioning Mech/Hot test

stimulus

Post-conditioning Mech/Hot test

stimulus

22N mechanical Conditioning

stimulus (2 minutes)

Conditioning stimulus continued

Methods: Conditioned Pain Modulation Testing

Page 177: PAIN AND SHOULDER

• Step 2: Conditioning stimulus for 2 minutes

– Noxious mechanical stimulus

– delivered using 2mm diameter probe pushed into the

antebrachium using a pneumatic device

Air

Methods: Conditioned Pain Modulation Testing

Page 178: PAIN AND SHOULDER

Step 1 Step 2 Step 3

Pre-conditioning Mech/Hot test

stimulus

Post-conditioning Mech/Hot test

stimulus

22N mechanical Conditioning

stimulus (2 minutes)

Conditioning stimulus continued

OR +

Methods: Conditioned Pain Modulation Testing

Page 179: PAIN AND SHOULDER

Step 1 Step 2 Step 3

Pre-conditioning Mech/Hot test

stimulus

Post-conditioning Mech/Hot test

stimulus∆ = Post-conditioning – Pre-conditioning threshold

Intact endogenous analgesic system: ↑ ∆Impaired endogenous analgesic system: ↓ ∆

Methods: Conditioned Pain Modulation Testing

Page 180: PAIN AND SHOULDER

Outcome Measures:

• Response to Analgesia –

– Liverpool Osteoarthritis in Dogs (LOAD)

– Canine Brief Pain Inventory (CBPI)

• Patient Phenotyping – Conditioned Pain Modulation (CPM)

– 2 test stimulus – mechanical and hot thermal

Page 181: PAIN AND SHOULDER

Methods: Statistical analysis

• Distribution of data was assessed by Shiro-Wilk test

• Parametric and non-parametric data was analyzed by the

t-test and Wilcoxon test respectively

• Logistic regression model was used to address effects of

covariates.

Page 182: PAIN AND SHOULDER

RESULTS

Page 183: PAIN AND SHOULDER

Results – Patient data

Page 184: PAIN AND SHOULDER

Patient demographics

Overall (n=52)

Age in years at start 7.55 ± 2.8

Weight (kg) 31.4 ± 9.9

BCS 5.3 ± 1.0 Sex MN n=21;

M n=2;

FS n=28;

F n=1

Page 185: PAIN AND SHOULDER

Patient demographics

Placebo-Meloxciam Sequence

(n=26)

Meloxciam-Placebo Sequence

(n=26)

P value

Age in years at start

8.1 ± 2.9; 8, (2 – 12) 7.0 ± 2.7; 7, (2 – 12) 0.160

Weight (kg) 31.5 ± 7.5; 29.5, (19.9 – 53) 31.2 ± 12.0; 29.9, (19 – 69.8) 0.900

BCS 5.2 ± 1.0; 5, (4 – 8) 5.4 ± 1.0; 5, (4 – 8) 0.580

Sex FS n=14/26;

MN n=12/26

MN n=9/26

M n=2/26

FS n=14/26

F n=1/26

0.330

Page 186: PAIN AND SHOULDER

Results - CMI Summary Table

∆ Meloxicam - ∆Placebo P-value

Liverpool Osteoarthritis in Dogs (LOAD)

2.95 ± 7.84 0.019

Canine Brief Pain Inventory (CBPI)

PSS: 0.94 ± 2.51 <0.001

PIS: 0.61 ± 2.24 <0.001

Both LOAD and CBPI showed a significant pain improvement after meloxicam administration as compared to placebo administration

-

-

-

(i.e. improvement)

(i.e. improvement)

(i.e. improvement)

Page 187: PAIN AND SHOULDER

Results - Conditioned Pain Modulation

(Blunt Mechanical) (g)

-9 ± 273

-1 ± 204

Page 188: PAIN AND SHOULDER

Results - Conditioned Pain Modulation

(Blunt Mechanical) (g)

-9 ± 273

-1 ± 204

∆ ~0: No improvement in CPM

Page 189: PAIN AND SHOULDER

Results - Conditioned Pain Modulation

(Blunt Mechanical) (g)

-9 ± 273

-1 ± 204

∆ >>0: Improvement in CPM

Page 190: PAIN AND SHOULDER

Results - Conditioned Pain Modulation

(Blunt Mechanical) (g) ∆

Page 191: PAIN AND SHOULDER

Results - Conditioned Pain Modulation

(Blunt Mechanical) (g)

-9 ± 273 g

-1 ± 204

Page 192: PAIN AND SHOULDER

P = 0.417

Results - Conditioned Pain Modulation

(Blunt Mechanical) (g)

Page 193: PAIN AND SHOULDER

Results - Conditioned Pain Modulation

(Hot Thermal) (s) ∆

Page 194: PAIN AND SHOULDER

Results - Conditioned Pain Modulation

(Hot Thermal) (s) ∆

Page 195: PAIN AND SHOULDER

Results - Conditioned Pain Modulation

(Hot Thermal) (s) ∆

0.45 ± 3.37s 0.47 ± 3.08 s

Page 196: PAIN AND SHOULDER

Results - Conditioned Pain Modulation

(Hot Thermal) (s) ∆

P = 0.460

Page 197: PAIN AND SHOULDER

Discussion – CPM

• Both the mechanical and thermal

testing did NOT support reversal

the EPM malfunction using

meloxicam

• Our study is first to report the

effect of an NSAID on dEPM in

dogs.

• Results similar to humans, Arendt-

Nielsen et al. showed etoricoxib

did not have an effect on CPM.

Arendt-Nielsen L et al Pain 2016

Page 198: PAIN AND SHOULDER

Discussion - Limitations

• Washout period was short – order effect

• Limited number of dogs – may not have addressed the

individual variation

Page 199: PAIN AND SHOULDER

Discussion – Clinical significance

• Meloxicam administration was not able to reverse

dysfunctional endogenous pain modulation in dogs with

persistent spontaneous OA pain.

• Evaluation of drugs that may reverse dEPM is warranted

to manage canine OA pain appropriately.

Page 200: PAIN AND SHOULDER

Thank you

• Boehringer Ingelheim Vetmedica

• B. Duncan X. Lascelles

• Jon Hash, Rachel Meyers, Andrea Thomson and

everyone at Comparative Pain and Education Center to

make it happen!

Page 201: PAIN AND SHOULDER

PAIN AND SHOULDER

OCTOBER 27, 2020 | 5:00–6:00 P.M. ET

Page 202: PAIN AND SHOULDER